IFN-α subtypes: distinct biological activities in anti-viral therapy.
about
Interferon-alpha, immune activation and immune dysfunction in treated HIV infectionHepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus controlInterferons and viruses: an evolutionary arms race of molecular interactionsThe Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.Interferons: Success in anti-viral immunotherapy.Induction of IFN-α subtypes and their antiviral activity in mumps virus infection.Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector MechanismsInterferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.cGAS Senses Human Cytomegalovirus and Induces Type I Interferon Responses in Human Monocyte-Derived Cells.Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.Interferons and HIV Infection: The Good, the Bad, and the UglyResistance to type 1 interferons is a major determinant of HIV-1 transmission fitnessControl of Hepatitis B Virus by CytokinesCytokine networking of innate immunity cells: a potential target of therapy.Modulatory effects on dendritic cells by human herpesvirus 6.Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses.Targeting IFN-λ: therapeutic implications.Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation.Relationship between IFNA1, IFNA5, IFNA10, and IFNA17 gene polymorphisms and Crimean-Congo hemorrhagic fever prognosis in a Turkish population range.Interferon-α-induced CD100 on naïve CD8+ T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction.In vivo evaluation of the efficacy of combined albedazole-IFN-α treatment for cystic echinococcosis in mice.Gene therapy with plasmids encoding IFN-β or IFN-α14 confers long-term resistance to HIV-1 in humanized mice.Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.A panel of synthetic antibodies that selectively recognize and antagonize members of the interferon alpha family.Human Immunodeficiency Virus 1 and Type I Interferons-Where Sex Makes a DifferenceIFN-λ1 in CHO cells: its expression and biological activity.Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection.Friend virus limits adaptive cellular immune responses by imprinting a maturation-resistant and T helper type 2-biased immunophenotype in dendritic cells.SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.Interferon-Mediated Response to Human Metapneumovirus Infection
P2860
Q26861003-B5739AC2-0329-4997-890D-5C83CF8FAFFFQ28082128-18BE54BE-94BE-42FA-A237-AA2EC1E8F894Q28083788-E65E508D-AF95-4720-BFCA-F352E47C78EDQ30486741-1DFA9442-8DB1-444C-89C3-1BF6B4403E1DQ33568321-8C55F4B1-A698-4790-A46E-30AC5E2D4168Q33734554-BA0F6ACF-29AA-456A-B13B-3AB62E4DB576Q34276038-069C2175-F1C1-434D-A3A0-36FB86DDE713Q34652461-7D599B35-DBE5-4DED-A8DE-275CFF26E948Q35830651-8380830D-4EB3-4259-9EDD-F78853F5051EQ35861186-DFB58F91-0C4B-4758-B216-EF4F76B9B9A0Q35983493-C5E05632-9A33-46E8-A1F2-D22B00A1F97FQ36450748-EA0E229C-6EFF-4E47-A90C-998C2A164212Q36730005-55019E9F-6C72-49A5-8FF3-CAEFFFA91F82Q37149862-DB86D907-654C-4E08-85CD-933B5ECDF495Q37612507-ACC94327-1CA1-4F9C-A2D8-27BDB3E27540Q37628224-313CC1D7-0C83-4F3A-8EF8-AFD9584E9DE7Q38180799-7028E513-3D17-4C98-966F-B6B0004AD3C9Q38487111-419DC373-4390-49B6-9C80-903574A2577AQ38523847-2409DE9D-46A9-48F1-A38F-AB797909F426Q38816811-EE690DDE-8C7B-4429-A45D-686CBD64FE3DQ39543822-3298C61E-85BA-4D88-B04A-D36A62B16C34Q40125890-F990420F-B947-472B-A9B7-A80829C66EF1Q40323617-76E7FF90-390D-43E0-B8C3-939BCC140C61Q40419200-BC282E43-496E-441E-BA7D-CAE08E49FCD1Q40510052-BEC871D0-F7B6-4563-B504-6ECA754CFE28Q40701192-00606D23-020B-471D-B877-477A19D5FAAAQ41923577-FBB4C169-199E-4688-AEF5-6E81C38A3F63Q42369099-B2DA3634-1F00-4A86-BEEA-CD22B8E5D23FQ47095129-21951DDA-9F5B-43B1-8214-F41AB56BCB83Q47555245-37E7E0C4-30C8-47BB-8B58-1312016A02CEQ50099421-5C1DCC3D-AF50-4664-9E2B-DDF5DC202989Q55342016-56253C87-5EBD-42E0-A5A4-44D22F875607Q58722893-EE1DA4EF-93BF-4F80-8813-8A6759EC9F3F
P2860
IFN-α subtypes: distinct biological activities in anti-viral therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
IFN-α subtypes: distinct biological activities in anti-viral therapy.
@ast
IFN-α subtypes: distinct biological activities in anti-viral therapy.
@en
type
label
IFN-α subtypes: distinct biological activities in anti-viral therapy.
@ast
IFN-α subtypes: distinct biological activities in anti-viral therapy.
@en
prefLabel
IFN-α subtypes: distinct biological activities in anti-viral therapy.
@ast
IFN-α subtypes: distinct biological activities in anti-viral therapy.
@en
P2093
P2860
P356
P1476
IFN-α subtypes: distinct biological activities in anti-viral therapy
@en
P2093
P2860
P304
P356
10.1111/BPH.12010
P407
P577
2013-03-01T00:00:00Z